Back to results
US 6,642,206 B2Granted
Monocyclic L-nucleosides, analogs and uses thereof
AssigneeICN Pharmaceuticals, Inc.
InventorsKanda Ramasamy, Robert Tam, Devron Averett
Life of this patent
Estimating the term…
Abstract
Novel monocyclic L-Nucleoside compounds have the general formula Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
Claims5
A compound having a structure according to Formula I:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.